FDA Approved: LIVMARLI — Original Application (Mirum Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved LIVMARLI (maralixibat chloride) from Mirum Pharmaceuticals as an original application for the treatment of pruritus in pediatric patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alagille Syndrome

Drugs mentioned

• LIVMARLI (Maralixibat chloride)

Snippet

ORIG AP for LIVMARLI (MARALIXIBAT CHLORIDE)